To include your compound in the COVID-19 Resource Center, submit it here.

PDLI, Roche amend Zenapax deal

In a revision to a 1999 deal, Protein Design Labs (PDLI) obtained exclusive worldwide rights from

Read the full 168 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE